Revium Rx COO and President Inna Martin Resigns Amid 'Differences in Expectations'
Summary
Revium Rx's COO and President, Inna Martin, has resigned, effective June 16, with employment terminating September 10. This follows the company's CFO resignation earlier this month and a series of negative financial reports, including repeated 'going concern' warnings. The 8-K filed moments before this news cited 'differences in expectations' as the reason for Martin's departure. The departure of two key executives within a month, particularly with stated internal disagreements, signals significant leadership instability and raises further concerns for a company already facing severe financial distress.
At the time of this announcement, RVRC was trading at $1.67 on OTC in the Life Sciences sector, with a market capitalization of approximately $101.4M. The 52-week trading range was $0.30 to $50.00. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.